Comparative Risk of Alzheimer Disease and Related Dementia Among Medicare Beneficiaries With Rheumatoid Arthritis Treated With Targeted Disease-Modifying Antirheumatic Agents [PDF]
, 2022 Rishi Desai +9 more
openalex +1 more source
Clinico-pharmacological studies and clinical evaluation of flurbiprofen. A new non-steroidal antirheumatic agent. [PDF]
, 1972 Ian Chalmers +4 more
openalex +1 more source
Comparison of Biological Agent Monotherapy and Associations Including Disease-Modifying Antirheumatic Drugs for Rheumatoid Arthritis: Literature Review and Meta-Analysis of Randomized Trials [PDF]
, 2022 Célia Delpech +2 more
openalex +1 more source
Magnetic resonance imaging in patients with rheumatoid arthritis with complete remission treated with disease-modifying antirheumatic drugs or anti-tumour necrosis factor agents [PDF]
, 2006 Marco Ulises Martínez‐Martínez +5 more
openalex +1 more source
Clinically used antirheumatic agent auranofin is a proteasomal deubiquitinase inhibitor and inhibits tumor growth [PDF]
, 2014 Ningning Liu +22 more
openalex +1 more source
Thyroid Autoimmunity and Function after Treatment with Biological Antirheumatic Agents in Rheumatoid Arthritis [PDF]
, 2017 Sofie Bliddal +2 more
openalex +1 more source
FRI0221 Does seropositivity influence differentially drug discontinuation of biologic antirheumatic agents with non-anti-tnf mode of action? [PDF]
, 2017 Axel Finckh +16 more
openalex +1 more source
Comparative Effectiveness of Tumor Necrosis Factor Agents and Disease-modifying Antirheumatic Therapy in Children with Enthesitis-related Arthritis: The First Year after Diagnosis [PDF]
, 2017 Pamela F. Weiss +7 more
openalex +1 more source